AMGN:  AMGEN is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. It concentrates on human therapeutics and focuses on medicines based on advances in cellular and molecular biology. Closing Price: 53.53 on 3/11/11 52-Week Price Range: 51.78-53.87 Risk: You need to further evaluate AMGN thoroughly. Well-informed, you decide what […]